| CAPOX Regimen studied in …STUDIED_INderived66 of 66show fewer |
|---|
| → studied in | NCT07700979Phase 3 · recruiting Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma · 66 trials list this drug (37 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482893Phase 1/Phase 2 · recruiting Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) · 66 trials list this drug (37 active) | — | — | Malignant Biliary Tract Neoplasm,Malignant Colorectal Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07221357Phase 2/Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07315750Phase 3 · recruiting A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. · 66 trials list this drug (37 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07728019Phase 2 · recruiting Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM · 66 trials list this drug (37 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132463Phase 3 · recruiting Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06246344Phase 3 · active not recruiting Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819604Phase 2 · not yet recruiting Serplulimab Combined With CAPOX and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821333Phase 2 · active not recruiting Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III · 66 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07221149Phase 2/Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) · 66 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07294664Phase 2 · recruiting PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer · 66 trials list this drug (37 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06949111Phase 2 · recruiting Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color） · 66 trials list this drug (37 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07057089Phase 2 · suspended Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I) · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07738042NA · not yet recruiting To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined With Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Rectal Cancer Under MSS/pMMR · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05322577Phase 1/Phase 2 · terminated A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. · 66 trials list this drug (37 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723534Phase 2 · not yet recruiting Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers · 66 trials list this drug (37 active) | — | — | Biliary Tract Carcinoma,Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686796Phase 3 · not yet recruiting Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial · 66 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07622017Phase 2 · not yet recruiting KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06567782Phase 2 · recruiting A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer · 66 trials list this drug (37 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03904043NA · completed Non-Operative Management and Early Response Assessment in Rectal Cancer · 66 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007182Phase 2 · recruiting Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer · 66 trials list this drug (37 active) | — | — | Gastric Neoplasm,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562503Phase 2 · recruiting Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07528209Phase 3 · recruiting Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Rectal Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475352Phase 2 · recruiting Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03259035Phase 2 · completed NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05515796Phase 2 · completed Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors · 66 trials list this drug (37 active) | — | — | Malignant Gastric Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472868Phase 3 · not yet recruiting Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Rectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05855200Phase 3 · recruiting Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer · 66 trials list this drug (37 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297030Phase 2 · not yet recruiting SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05008809Phase 3 · recruiting Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418) · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03984578Phase 2 · completed Window of Opportunity Study in Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07154316Phase 2 · recruiting Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05576480Phase 2 · recruiting SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06919510Phase 2 · not yet recruiting A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05646511Phase 3 · recruiting TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05379790Phase 1 · completed Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin · 66 trials list this drug (37 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06899477Phase 3 · not yet recruiting Pre-Operative Treatment in REseCTable COlon CanceR · 66 trials list this drug (37 active) | — | — | Colon Neoplasm,Colon Carcinoma,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643070Phase 2 · completed Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases · 66 trials list this drug (37 active) | — | — | Rectal Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06709885Phase 2 · recruiting HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer · 66 trials list this drug (37 active) | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03228043NA · withdrawn Apatinib for Resectable Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086627Phase 2 · completed Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06516445Phase 2 · unknown SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06443671Phase 2/Phase 3 · not yet recruiting Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03714490Phase 2 · unknown MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer · 66 trials list this drug (37 active) | — | — | Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014372Phase 2 · unknown Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05912075Phase 1 · recruiting Preoperative Radiotherapy And ASTX660 in Rectum Cancer · 66 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03840239Phase 2 · active not recruiting TNT to Increase the Clinical Complete Response Rate for Distal LARC · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06068023recruiting The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. · 66 trials list this drug (37 active) | — | — | Ampulla of Vater Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00958737Phase 3 · unknown Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04259944Phase 2 · unknown Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial · 66 trials list this drug (37 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969847Phase 2 · not yet recruiting Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05833672Phase 2 · unknown Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers · 66 trials list this drug (37 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05588297Phase 2 · unknown Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases · 66 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05201430Phase 3 · recruiting Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04418895Phase 2 · withdrawn Neoadjuvant Therapy for Localized Rectal Adenocarcinoma · 66 trials list this drug (37 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05068206Phase 2 · unknown A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04620473Phase 2 · withdrawn Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02114359Phase 3 · completed Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer · 66 trials list this drug (37 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02298010completed Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial · 66 trials list this drug (37 active) | — | — | Gastric Neoplasm,Malignant Lymph Node Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506167completed An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN) · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387387Phase 1 · completed Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) · 66 trials list this drug (37 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03280407Phase 2 · unknown NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Intestinal Neoplasm,Colorectal Neoplasm,Malignant Colorectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01952951Phase 2 · unknown Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer · 66 trials list this drug (37 active) | — | — | Adenocarcinoma,Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03038217Phase 3 · unknown Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00677443Phase 3 · completed Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00220116Phase 2 · completed Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer · 66 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |